Tag: B.S.1

Poster-Rehabilitation Poster

Validation and Minimal Detectable Change of the Walking While Talking Test As a Measure of Dual-Task Performance in Ambulatory Individuals with Multiple Sclerosis

Background: Multiple Sclerosis (MS) is a progressive neurodegenerative disease associated with demyelination of the central nervous system...

Read More

Poster-Neurophysiology; Neuropsychology and Neuropsychiatry

Examining the Influence of Processing Speed on the Relation between Backward Walking and Falls in Persons with Multiple Sclerosis

Background: Backward walking (BW) is a complex motor task that requires increased cognitive demands. In persons with multiple sclerosis...

Read More

Poster-Non-imaging Biomarkers

Validating the Clinical Usefulness of the Timed 25-Foot Walk in MS in Routine Clinical Practice

Background: Multiple Sclerosis (MS) is a chronic and degenerative autoimmune disease of the central nervous system which can cause...

Read More

Poster-Disease-modifying Therapy

Does Frequency and Severity of COVID-19 Differ By Disease Modifying Therapy in MS Patients?

Background: Some authors have reported positive associations between B-cell-depleting (anti-CD20) therapies and COVID-19 infection risk or...

Read More

Poster-Disease-modifying Therapy

Is There ‘Wearing Off’ with Ocrelizumab? Preliminary Results of Symptom Burden on Ocrelizumab, a Longitudinal Study (SymBOLS).

Background: Ocrelizumab (OCR), a humanized, anti-CD20 antibody therapy approved for multiple sclerosis (MS), is given at 6-month intervals....

Read More